Dompé

San Mateo,  CA 
United States
  • Booth: 73

Thank you for visiting the Dompé exhibit booth.
 

For more information about Oxervate, please contact one of our representatives below: 

Misti Jones - Misti.Jones@dompe.com
Tracy Melone - Tracy.Melone@dompe.com
Trish Sullivan  - Trish.Sullivan@dompe.com

Dompé is an Italian biopharmaceutical company based in Milan with US headquarters in the San Francisco Bay Area. It has a 100+ year legacy of medical innovation, and is committed to seeking further advances that address unmet medical needs in the areas of ophthalmology, transplants, oncology and diabetes. This commitment to innovation has resulted in successful development collaborations with over 200 centers of excellence. Dompé’s commitment to ophthalmology includes the first topical biologic FDA-approved for an ophthalmic indication, and continued exploration of new indications through ongoing trials.

Brands: Oxervate


 Videos

Patient Case Discussion: Treating Stage 2 Neurotrophic Keratitis With Oxervate
Welcome to our Dompé Virtual Booth!

 Press Releases


 Products

  • OXERVATE
    OXERVATE is the first FDA-approved treatment for people with neurotrophic keratitis. The main ingredient of OXERVATE is cenegermin, a recombinant form of human nerve growth factor....

  • For more information please visit our website, https://oxervate.com/
For technical assistance with this webpage please click here.